Ricardo F. Medina

Ricardo F. Medina, Ph.D., currently serves as Senior Scientist II at Blueprint Medicines since November 2022, following previous roles as Senior Scientist at Foghorn Therapeutics, Inc. and as a Scientist II and I at Blueprint Medicines. With extensive experience in developing cell-based assays and validating targets in immuno-oncology and cancer metabolism, Ricardo's research has involved essential gene functions and cellular phenotypes in relevant models. Prior experience includes positions as a Scientist at Agios Pharmaceuticals and as an Instructor and Postdoctoral Fellow at UMass Medical School, focusing on gene knock out models, cell cycle control, and chromatin remodeling. Ricardo holds a Ph.D. in Biological Sciences and has degrees in Biochemistry from Universidad de Concepción.